1. Home
  2. CRGX vs SCHL Comparison

CRGX vs SCHL Comparison

Compare CRGX & SCHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • SCHL
  • Stock Information
  • Founded
  • CRGX 2021
  • SCHL 1920
  • Country
  • CRGX United States
  • SCHL United States
  • Employees
  • CRGX N/A
  • SCHL N/A
  • Industry
  • CRGX
  • SCHL Books
  • Sector
  • CRGX
  • SCHL Consumer Discretionary
  • Exchange
  • CRGX Nasdaq
  • SCHL Nasdaq
  • Market Cap
  • CRGX 964.5M
  • SCHL 838.6M
  • IPO Year
  • CRGX 2023
  • SCHL 1987
  • Fundamental
  • Price
  • CRGX $12.81
  • SCHL $25.68
  • Analyst Decision
  • CRGX Strong Buy
  • SCHL
  • Analyst Count
  • CRGX 6
  • SCHL 0
  • Target Price
  • CRGX $31.80
  • SCHL N/A
  • AVG Volume (30 Days)
  • CRGX 229.0K
  • SCHL 210.2K
  • Earning Date
  • CRGX 11-12-2024
  • SCHL 12-19-2024
  • Dividend Yield
  • CRGX N/A
  • SCHL 3.22%
  • EPS Growth
  • CRGX N/A
  • SCHL N/A
  • EPS
  • CRGX N/A
  • SCHL 0.81
  • Revenue
  • CRGX N/A
  • SCHL $1,598,400,000.00
  • Revenue This Year
  • CRGX N/A
  • SCHL $6.25
  • Revenue Next Year
  • CRGX N/A
  • SCHL $4.85
  • P/E Ratio
  • CRGX N/A
  • SCHL $30.53
  • Revenue Growth
  • CRGX N/A
  • SCHL N/A
  • 52 Week Low
  • CRGX $12.58
  • SCHL $23.69
  • 52 Week High
  • CRGX $33.92
  • SCHL $40.74
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 30.99
  • SCHL 41.88
  • Support Level
  • CRGX $13.33
  • SCHL $25.22
  • Resistance Level
  • CRGX $15.26
  • SCHL $26.05
  • Average True Range (ATR)
  • CRGX 1.36
  • SCHL 0.78
  • MACD
  • CRGX -0.30
  • SCHL -0.11
  • Stochastic Oscillator
  • CRGX 3.51
  • SCHL 0.63

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

About SCHL Scholastic Corporation

Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.

Share on Social Networks: